Home > Newsletters > Drug Industry Daily > Specification Concerns Prompt Recall, MHRA Alert on Sanofi Pasteur Typhoid Vaccine
Drug Industry Daily
Oct. 10, 2012 | Vol. 11 No. 199
Specification Concerns Prompt Recall, MHRA Alert on Sanofi Pasteur Typhoid Vaccine
Sanofi Pasteur MSD, a Merck-Sanofi vaccine venture, is recalling 16 batches of its typhoid vaccine Typhim Vi after recent investigations found some syringes may have sub-potent antigen levels, the Medicines and Healthcare products Regulatory Agency (MHRA) says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.